TALTZ (Eli Lilly and Company)
Welcome to the PulseAid listing for the TALTZ drug offered from Eli Lilly and Company. This Interleukin-17A Antagonist [EPC],Interleukin-17A Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
| NON-PROPRIETARY NAME: | ixekizumab |
| SUBSTANCE NAME: | IXEKIZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Interleukin-17A Antagonist [EPC],Interleukin-17A Antagonists [MoA] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-03-22 |
| END MARKETING DATE: | 0000-00-00 |
TALTZ HUMAN PRESCRIPTION DRUG Details:
| Item Description | TALTZ from Eli Lilly and Company |
| LABELER NAME: | Eli Lilly and Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 80(mg/mL) |
| START MARKETING DATE: | 2016-03-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0002-1445_5c2a6042-dbd8-4de7-bc34-857f47869974 |
| PRODUCT NDC: | 0002-1445 |
| APPLICATION NUMBER: | BLA125521 |
Other IXEKIZUMAB Pharmaceutical Manufacturers / Labelers:
